Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Giovanni Gabutti, Niccolò Bolognesi, Federica Sandri, Caterina Florescu & Armando Stefanati. (2019) Varicella zoster virus vaccines: an update. ImmunoTargets and Therapy 8, pages 15-28.
Read now
Read now
Hervé Haas, Patrick Richard, Cécile Eymin, Anne Fiquet, Barbara Kuter & Benoit Soubeyrand. (2019) Immunogenicity and safety of intramuscular versus subcutaneous administration of a combined measles, mumps, rubella, and varicella vaccine to children 12 to 18 months of age. Human Vaccines & Immunotherapeutics 15:4, pages 778-785.
Read now
Read now
Silvia Cocchio, Giovanna Zanoni, Roberta Opri, Francesca Russo & Vincenzo Baldo. (2016) A postmarket safety comparison of 2 vaccination strategies for measles, mumps, rubella and varicella in Italy. Human Vaccines & Immunotherapeutics 12:3, pages 651-654.
Read now
Read now
Articles from other publishers (10)
O. A. Shamsutdinova, D. V. Bulgin, D. D. Karal-Ogly & I. N. Lavrent’eva. (2021) Analysis of Morphological Changes in the CNS and Internal Organs of Macaca mulatta Monkeys after Intracerebral Injection of a Low-Attenuated Rubella Virus Strain. Bulletin of Experimental Biology and Medicine 171:5, pages 671-675.
Crossref
Crossref
Roman Prymula, Michael Povey, Jerzy Brzostek, Hana Cabrnochova, Roman Chlibek, Hanna Czajka, Giedra Leviniene, Sorin Man, Mihai Neamtu, Petr Pazdiora, Doina Plesca, Renata Ruzkova, Maria Stefkovicova, Vytautas Usonis, Daniela Verdanova, Jacek Wysocki, Giacomo Casabona & Md Ahsan Habib. (2021) Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries. Vaccine 39:19, pages 2643-2651.
Crossref
Crossref
Luis Furuya-Kanamori, Paul Dutton, Alan Leeb, Deborah J Mills, Ross Andrews & Colleen L Lau. (2021) Adverse Events Following Immunization With Combined vs Concurrent Monovalent Hepatitis A and Typhoid Vaccines in Children. Journal of the Pediatric Infectious Diseases Society 10:2, pages 192-195.
Crossref
Crossref
Joshua Chapman, Ashley Finch, José García, Christian Williams & Mark Nelson. (2020) Is the combination measles, mumps, rubella, and varicella vaccine as immunogenic and safe as providing the MMR and varicella vaccines separately?. Evidence-Based Practice 23:12, pages 42-43.
Crossref
Crossref
Paolo Bellavite & Alberto Donzelli. (2021) Adverse events following measles-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data. F1000Research 9, pages 1176.
Crossref
Crossref
Paolo Bellavite & Alberto Donzelli. (2020) Adverse events following measles-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data. F1000Research 9, pages 1176.
Crossref
Crossref
Laura Brunelli, Federico Romanese, Pier Paolo Benetollo, Andrea Iob, MariaRita Forgiarini, Pierlanfranco D'Agaro, Francesca Valent, Silvio Brusaferro, Luca Arnoldo, Matteo Bassetti, Gianni Borghi, Giorgio Brianti, Patrizia Brunetti, Mirella Campagnolo, Giovanni Cattani, Paola Cogo, Marco Del Negro, Anna Fabbro, Tolinda Gallo, Paolo Lubrano, Fabio Marchetti, Stefano Miceli, Agostino Nocerino, Luca Paravano, Piero Pascolo, Maurizio Perna, Paolo Pischiutti, Andrea Plazzotta, Laura Regattin, Bruno Sacher, Massimo Sigon, Andrea Taddio, Tiziano Tommasini & Erica Vacchiano. (2019) Management of reduced vaccine coverage due to 6 years of failure to vaccinate: The Codroipo case, Italy. Vaccine 37:17, pages 2294-2297.
Crossref
Crossref
Petra Zimmermann & Nigel Curtis. (2019) Factors That Influence the Immune Response to Vaccination. Clinical Microbiology Reviews 32:2.
Crossref
Crossref
Ouzama Henry, Jerzy Brzostek, Hanna Czajka, Giedra Leviniene, Olga Reshetko, Roberto Gasparini, Petr Pazdiora, Doina Plesca, Maria Giuseppina Desole, Rimantas Kevalas, Giovanni Gabutti, Michael Povey & Bruce Innis. (2018) One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life. Vaccine 36:3, pages 381-387.
Crossref
Crossref
Lili Wang, Lucy Zhu & Hua Zhu. (2016) Efficacy of varicella (VZV) vaccination: an update for the clinician. Therapeutic Advances in Vaccines 4:1-2, pages 20-31.
Crossref
Crossref